IL98655A0 - Improved adjuvants and vaccines - Google Patents

Improved adjuvants and vaccines

Info

Publication number
IL98655A0
IL98655A0 IL98655A IL9865591A IL98655A0 IL 98655 A0 IL98655 A0 IL 98655A0 IL 98655 A IL98655 A IL 98655A IL 9865591 A IL9865591 A IL 9865591A IL 98655 A0 IL98655 A0 IL 98655A0
Authority
IL
Israel
Prior art keywords
antigen
isotype
present
vaccines
admixed
Prior art date
Application number
IL98655A
Other languages
English (en)
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of IL98655A0 publication Critical patent/IL98655A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL98655A 1990-06-27 1991-06-27 Improved adjuvants and vaccines IL98655A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54483190A 1990-06-27 1990-06-27
US71680791A 1991-06-21 1991-06-21

Publications (1)

Publication Number Publication Date
IL98655A0 true IL98655A0 (en) 1992-07-15

Family

ID=27067746

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98655A IL98655A0 (en) 1990-06-27 1991-06-27 Improved adjuvants and vaccines

Country Status (17)

Country Link
EP (1) EP0536302B1 (de)
JP (1) JPH0832639B2 (de)
KR (1) KR100218138B1 (de)
CN (1) CN1060027A (de)
AT (1) ATE157259T1 (de)
AU (1) AU655593B2 (de)
BR (1) BR9106601A (de)
CA (1) CA2086097C (de)
DE (1) DE69127445T2 (de)
DK (1) DK0536302T3 (de)
ES (1) ES2104712T3 (de)
GR (1) GR3025341T3 (de)
IE (1) IE912257A1 (de)
IL (1) IL98655A0 (de)
NZ (1) NZ238731A (de)
PT (1) PT98119B (de)
WO (1) WO1992000101A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3723231B2 (ja) * 1991-12-23 2005-12-07 ディミナコ アクチェンゲゼルシャフト アジュバント
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US5407585A (en) * 1993-08-16 1995-04-18 Exxon Chemical Patents Inc. Method of demulsifying water-in-oil emulsions
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
EP1181937A3 (de) * 1994-08-09 2004-02-04 Cytrx Corporation Nukleinsäure enthaltender Impfstoff, Impfstoff-adjuvans
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
WO1998013069A2 (en) 1996-09-09 1998-04-02 Supratek Pharma, Inc. Fluorinated copolymeric pharmaceutical adjuncts
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
US6368604B1 (en) 1997-09-26 2002-04-09 University Of Maryland Biotechnology Institute Non-pyrogenic derivatives of lipid A
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
US7256180B2 (en) 2000-04-28 2007-08-14 Supratek Pharma Inc. Compositions and methods for inducing activation of dendritic cells
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
CN113527417B (zh) * 2021-07-05 2022-09-27 中国医学科学院放射医学研究所 一种含氟基团的自组装多肽纳米佐剂及其制备方法与应用
WO2026114933A1 (en) * 2024-11-27 2026-06-04 Intervet International B.V. Stable vaccine against streptococcus suis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609546A (en) * 1982-06-24 1986-09-02 Japan Chemical Research Co., Ltd. Long-acting composition
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants

Also Published As

Publication number Publication date
DE69127445D1 (de) 1997-10-02
CN1060027A (zh) 1992-04-08
ATE157259T1 (de) 1997-09-15
PT98119A (pt) 1992-04-30
PT98119B (pt) 1998-12-31
IE912257A1 (en) 1992-01-01
AU8286191A (en) 1992-01-23
NZ238731A (en) 1996-02-27
EP0536302B1 (de) 1997-08-27
GR3025341T3 (en) 1998-02-27
EP0536302A4 (en) 1993-08-04
DK0536302T3 (da) 1997-09-29
EP0536302A1 (de) 1993-04-14
JPH05507498A (ja) 1993-10-28
WO1992000101A1 (en) 1992-01-09
CA2086097C (en) 2001-06-12
DE69127445T2 (de) 1998-03-19
ES2104712T3 (es) 1997-10-16
KR100218138B1 (en) 1999-09-01
AU655593B2 (en) 1995-01-05
BR9106601A (pt) 1993-04-20
JPH0832639B2 (ja) 1996-03-29
CA2086097A1 (en) 1991-12-28

Similar Documents

Publication Publication Date Title
GR3025341T3 (en) Improved adjuvants and vaccines
DE69225471D1 (de) Abgeschwächtes, gentechnologisch hergestelltes pseudorabies virus s-prv-155 und seine verwendungen
DE69332518D1 (de) Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
NZ323973A (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
BR0007936A (pt) Composto, formulação adjuvante imunológica, formulação de vacina, e, processo para estimular uma resposta imune a um antìgeno
FI943171A0 (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
EP1379270A4 (de) Verfahren zur induzierung von immuntoleranz
EP0881910A4 (de) Verwendung von immunokonjugaten zur erhöhung der effektivität von mehrstufigen kaskaden-impfstoffen
DE69333730D1 (de) Impfstoff, der acemannan als adjuvans enthält
GR3018529T3 (en) Nematode vaccine.
ATE234109T1 (de) Cetp zur erhöhung des hdl-cholesterol-gehalts
PT603386E (pt) Imunizacao parenterica contra rotavirus
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
Kiseleva et al. Comparative study of the concentration of antibodies and protective activity to Pseudomonas aeruginosa in the preparations of gamma globulin and IgM-enriched immunoglobulin.
DE69322960D1 (de) Empfängnisverhütender impfstoff
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
Watanabe et al. Immunity in cholera
Kurochkina et al. The impairment of antitoxic antitetanus immunity due to the combined effect of radiation and heat
WO2005041890A3 (en) Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
KR950701683A (ko) 클로스트리디움 퍼프린겐스 백신(Clostridium perfringens wvaccines)
MX9707295A (es) Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10.